The Affordable Care Act (ACA) has led to increased guideline-concordant care for colon cancer among non-white patients, ...

Taking race into account when developing tools to predict a patient's risk of colorectal cancer leads to more accurate ...

For the past year, Kulkarni had noticed some gastrointestinal issues, but he suspected it was nothing more than irritable ...

Exact Sciences, which has for years sold a stool-based colon cancer test, on Monday announced that a blood-based test it’s developing showed promise in accurately detecting the disease.

Colorectal cancer, also known as bowel cancer, is a cancer formed by uncontrolled cell growth in the colon or rectum (parts of the large intestine), or in the appendix. Genetic analysis shows that ...

Colon cancer is the disease characterized by the development of malignant cells in the lining or epithelium of the first and longest portion of the large intestine. In the phase 2 NICHE-3 trial ...

The initial results of the IMbrave050 trial raised hopes that an effective adjuvant regimen for hepatocellular carcinoma (HCC) might finally have arrived. Patients with HCC treated with a ...

achieving an accuracy of 98% in classifying the TNM stages. Additionally, we tested the YOLOv8 Small model on another dataset, the Lung3 dataset from the Cancer Imaging Archive (TCIA). This testing ...

Sep. 5, 2024 — Staging of patients with early pancreatic cancer is inaccurate as much as 80% of the time, according to a new study. The finding underscores the urgent need for advancements in ...

Tumor-Induced B Cell Changes Reveal Potential Biomarker for Treatment Response in Triple Negative Breast Cancer Sep. 12, 2024 — Researchers have discovered new insights into tumor-induced B cell ...

The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...